From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: was this Zak Mir's worst ever (undeclared) paid for forecast ever?

By Tom Winnifrith | Thursday 25 August 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with a joke the late Steve Holdsworth would have appreciated for I can confirm that reports of his death were, sadly, not exaggerated. Then onto two US oil plays where I see big troubles ahead: Canadian Overseas Petroleum (COPL) and Zephyr Energy (ZPHR). Then onto the failings of Aquis in covering up the sins of disgraced Graham Mullis at Love Hemp (LIFE) and onto another shocker from the lobster pot Evrima (EVA), hat tip M for that one. Finally, a detailed look at Powerhouse Energy (PHE), its dismal interims, Zak's appalling forecast/plain paid for ramping and the looming cash crisis set to unfold by this time next year. The big tent for ShareStock arrived today. Gosh it is heavy. I am dreading trying to put it up. To get inside it book your seats HERE.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 08:13:08